Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD006466.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 diciembre 2010see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Cáncer ginecológico, neurooncología y otros cánceres

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Elie A Akl

    Correspondencia a: Department of Medicine, State University of New York at Buffalo, Buffalo, USA

    [email protected]

  • Srinivasa Rao Vasireddi

    Missouri State University, Springfield, USA

  • Sameer Gunukula

    Department of Medicine, State University of New York at Buffalo, Buffalo, USA

  • Victor E D Yosuico

    Department of Medicine, State University of New York at Buffalo, Buffalo, USA

  • Maddalena Barba

    INFORMA/CLARITY Research/Department of Epidemiology, National Cancer Institute Regina Elena, Rome, Italy

  • Irene Terrenato

    Department of Epidemiology, National Cancer Institute Regina Elena, Rome, Italy

  • Francesca Sperati

    Department of Epidemiology, National Cancer Institute Regina Elena, Rome, Italy

  • Holger Schünemann

    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada

Contributions of authors

EAA: protocol development, search for trials, screening, data extraction, data analysis, manuscript drafting, review coordination. GK: screening, search for trials, full text retrieval, data extraction. SYK: search for trials, screening. VY: full text retrieval, data extraction. MB: screening. IT: data analysis. FS: data analysis. HJS: protocol development, search for trials, data analysis, methodological advice.

Sources of support

Internal sources

  • Sate University of New York at Buffalo, Department of Medicine, USA.

  • Italian National Cancer Institute Regina Elena, Rome, Italy.

External sources

  • Research Grants, Not specified.

    H Schünemann: no personal payments from for‐profit sponsors, research grants and honoraria were received into research accounts or received by a research group that he belongs to from AstraZeneca, Amgen, Chiesi Foundation, Lily, and Pfizer, Roche and UnitedBioSource for development or consulting regarding quality of life instruments for chronic respiratory diseases and as lecture fees related to the methodology of evidence based practice guideline development and research methodology. Institutions or organizations that he is affiliated with likely receive funding from for‐profit sponsors that are supporting infrastructure and research that may serve his work.

Declarations of interest

HJS: no personal payments from for‐profit sponsors related to the subject matter in the past three years. EAA and HJS are executive committee members of the ACCP Antithrombotic Therapy Guidelines.

Acknowledgements

We thank Dr. Daly, Dr. Levine, Dr. Maurer and Dr. Zacharski for providing us with available data. We thank Ms. Ann Grifasi for her administrative support.

Version history

Published

Title

Stage

Authors

Version

2021 Oct 08

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation

Review

Lara A Kahale, Charbel F Matar, Ibrahim G Tsolakian, Maram B Hakoum, Maddalena Barba, Victor ED Yosuico, Irene Terrenato, Francesca Sperati, Holger Schünemann, Elie A Akl

https://doi.org/10.1002/14651858.CD006466.pub7

2017 Dec 29

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation

Review

Lara A Kahale, Maram B Hakoum, Ibrahim G Tsolakian, Charbel F Matar, Maddalena Barba, Victor ED Yosuico, Irene Terrenato, Francesca Sperati, Holger Schünemann, Elie A Akl

https://doi.org/10.1002/14651858.CD006466.pub6

2014 Jul 01

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

Review

Elie A Akl, Lara Kahale, Irene Terrenato, Ignacio Neumann, Victor E D Yosuico, Maddalena Barba, Francesca Sperati, Holger Schünemann

https://doi.org/10.1002/14651858.CD006466.pub5

2014 Jun 04

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

Review

Elie A Akl, Lara Kahale, Irene Terrenato, Ignacio Neumann, Victor E D Yosuico, Maddalena Barba, Francesca Sperati, Holger Schünemann

https://doi.org/10.1002/14651858.CD006466.pub4

2011 Jun 15

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

Review

Elie A Akl, Srinivasa Rao Vasireddi, Sameer Gunukula, Victor E D Yosuico, Maddalena Barba, Irene Terrenato, Francesca Sperati, Holger Schünemann

https://doi.org/10.1002/14651858.CD006466.pub3

2010 Dec 08

Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

Review

Elie A Akl, Srinivasa Rao Vasireddi, Sameer Gunukula, Victor E D Yosuico, Maddalena Barba, Irene Terrenato, Francesca Sperati, Holger Schünemann

https://doi.org/10.1002/14651858.CD006466.pub2

2007 Apr 18

Oral anticoagulation for prolonging survival in patients with cancer

Review

Elie A Akl, Ganesh Kamath, Seo Young Kim, Victor E D Yosuico, Maddalena Barba, Irene Terrenato, Francesca Sperati, Holger Schünemann

https://doi.org/10.1002/14651858.CD006466

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.